Wen-Juan Yu Selected Research

Wen-Juan Yu Research Topics

Disease

4	Neoplasms (Cancer) 01/2020 - 07/2013
3	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 08/2022 - 01/2016
3	Leukemia 01/2020 - 10/2007
2	Infections 08/2022 - 07/2019
2	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2020 - 12/2016
1	Fever (Fevers) 08/2022
1	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 01/2021
1	Multi-centric Castleman's Disease 02/2020
1	Renal Insufficiency (Renal Failure) 02/2020
1	Disease Progression 02/2020
1	Hyperglycemia 01/2020
1	Sarcoma (Soft Tissue Sarcoma) 01/2020
1	Diabetes Mellitus 01/2020
1	Renal Cell Carcinoma (Grawitz Tumor) 01/2020
1	Perivascular Epithelioid Cell Neoplasms 01/2020
1	Philadelphia Chromosome 01/2020
1	Residual Neoplasm 12/2016
1	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2016
1	Hepatocellular Carcinoma (Hepatoma) 01/2015
1	Hemangioma (Angioma) 01/2015
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 03/2014
1	Squamous Cell Carcinoma of Head and Neck 07/2013
1	Parkinson Disease (Parkinson's Disease) 07/2013
1	Epilepsy (Aura) 02/2012
1	Seizures (Absence Seizure) 02/2012
1	Peripheral Nervous System Diseases (PNS Diseases) 01/2012
1	Diabetes Complications 01/2012
1	Invasive Fungal Infections 07/2011
1	Hematologic Neoplasms (Hematological Malignancy) 07/2011
1	Diabetic Retinopathy (Retinopathy, Diabetic) 06/2011
1	Hypoxia (Hypoxemia) 05/2010
1	Plasmacytoma 06/2009
1	Jaundice (Icterus) 06/2009
1	Brain Ischemia (Cerebral Ischemia) 04/2009
1	Reperfusion Injury 04/2009

Drug/Important Bio-Agent (IBA)

2	Decitabine FDA Link 08/2022 - 01/2016
2	RNA (Ribonucleic Acid)IBA 01/2020 - 07/2019
1	venetoclaxIBA 08/2022
1	Azacitidine (5 Azacytidine)FDA Link 08/2022
1	Hemoglobins (Hemoglobin)IBA 08/2022
1	Lenalidomide (CC 5013)FDA Link 02/2020
1	Prednisone (Sone)FDA LinkGeneric 01/2020
1	Biological ProductsIBA 01/2020
1	AsparagineIBA 01/2020
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2020
1	Vascular Endothelial Growth Factor Receptor-1 (fms-Like Tyrosine Kinase)IBA 01/2020
1	Dasatinib (BMS 354825)FDA Link 01/2020
1	MicroRNAs (MicroRNA)IBA 07/2019
1	Messenger RNA (mRNA)IBA 07/2019
1	Idarubicin (4 Demethoxydaunorubicin)FDA LinkGeneric 01/2016
1	Cytarabine (Cytosar-U)FDA LinkGeneric 01/2016
1	Keratins (Keratin)IBA 01/2015
1	thiazolyl blueIBA 03/2014
1	KinesinsIBA 03/2014
1	Small Interfering RNA (siRNA)IBA 03/2014
1	BromidesIBA 07/2013
1	Fluorouracil (Carac)FDA LinkGeneric 07/2013
1	alpha-SynucleinIBA 07/2013
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 02/2012
1	Pentylenetetrazole (Metrazol)IBA 02/2012
1	GABA-A Receptor AntagonistsIBA 02/2012
1	Aminobutyrates (Aminobutyric Acid)IBA 02/2012
1	NAD (NADH)IBA 01/2012
1	Voriconazole (Vfend)FDA LinkGeneric 07/2011
1	Oxygen (Dioxygen)IBA 06/2011
1	Nerve Growth Factors (Neurotrophins)IBA 05/2010
1	Bortezomib (Velcade)FDA Link 06/2009
1	Nitric Oxide Synthase (NO Synthase)IBA 04/2009
1	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 04/2009
1	erucylphosphocholineIBA 04/2009
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 04/2009
1	tanespimycin (17AAG)IBA 10/2007
1	Heat-Shock Proteins (Heat-Shock Protein)IBA 10/2007

Therapy/Procedure

5	Drug Therapy (Chemotherapy) 01/2021 - 06/2009
2	Nephrectomy 01/2015 - 01/2015
1	Hematopoietic Stem Cell Transplantation 01/2021
1	Therapeutics 02/2020
1	Renal Dialysis (Hemodialysis) 02/2020
1	Induction Chemotherapy 12/2016
1	Aftercare (After-Treatment) 12/2016
1	Electroacupuncture 04/2009